Yan, D., Franzini, A., Pomicter, A. D., Halverson, B. J., Antelope, O., Mason, C. C., . . . Deininger, M. W. (2021). SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia. Blood Cancer Discov.
Citação norma ChicagoYan, Dongqing, et al. "SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia." Blood Cancer Discov 2021.
ציטוט MLAYan, Dongqing, et al. "SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia." Blood Cancer Discov 2021.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.